• Dopamine Receptor D4 (DRD4) Genotyping
  • Avantect Ovarian Cancer Test
  • EdenDx Methylation Assay (CDO1 and CELF4) for Early Detection of Endometrial Cancer
  • Pulmonary embolism
  • Carbamazepine Profile, Serum
  • Secobarbital, Serum
  • Programmed death-ligand 1 (PD-L1) by Immunohistochemistry (IHC)
  • Chronic Fatigue Syndrome Diagnostic Panel
  • Pseudoephedrine, Urine
  • DNA Methylation Gene Panel for Barrett's Esophagus (EndoSign®)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Reference Ranges
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...